Cargando…

Procalcitonin as a marker of bacterial sepsis in immunocompromised patients

Detalles Bibliográficos
Autores principales:	Gatserelia, Lana, Sharvadze, Lali, Karchava, Marine, Babridze, Nino, Tsetvadze, Tengiz, Dvali, Natia, Dzigua, Lela, Chxartishvili, Nika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360284/ http://dx.doi.org/10.1186/1742-4690-9-S1-P90

Ejemplares similares

The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia
por: Tsertsvadze, Tengiz, et al.
Publicado: (2016)

Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
por: Chkhartishvili, Nikoloz, et al.
Publicado: (2014)

Etiologic Agents of Central Nervous System Infections among Febrile Hospitalized Patients in the Country of Georgia
por: Akhvlediani, Tamar, et al.
Publicado: (2014)

Late presentation of HIV infection in the country of Georgia: 2012-2015
por: Chkhartishvili, Nikoloz, et al.
Publicado: (2017)

Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia
por: Tsertsvadze, Tengiz, et al.
Publicado: (2011)

Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia
por: Chkhartishvili, Nikoloz, et al.
Publicado: (2013)

An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia’s corrections system, December 2013 – April 2015
por: Harris, Aaron M., et al.
Publicado: (2019)

Evaluation of multiple measures of antiretroviral adherence in the Eastern European country of Georgia
por: Chkhartishvili, Nikoloz, et al.
Publicado: (2014)

Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients
por: Bele, Nicolas, et al.
Publicado: (2011)

The prevalence of hyperglycemia and its impact on mortality among people living with HIV in Georgia
por: Borkowska, Tea, et al.
Publicado: (2022)

Combination of C-Reactive Protein and Procalcitonin in Distinguishing Fungal from Bacterial Infections Early in Immunocompromised Children
por: Liu, Yingli, et al.
Publicado: (2022)

Procalcitonin as a prognostic marker for sepsis based on SEPSIS‐3
por: Jekarl, Dong Wook, et al.
Publicado: (2019)

Serum procalcitonin in sepsis
por: Wiwanitkit, Viroj
Publicado: (2011)

Procalcitonin in paediatric sepsis
por: Hatherill, M, et al.
Publicado: (1998)

Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis
por: Li, Shuhua, et al.
Publicado: (2016)

High Yield of Active Tuberculosis Case Finding Among HIV-Infected Patients Using Xpert MTB/RIF Testing
por: Kempker, Russell R, et al.
Publicado: (2019)

Sepsis in Immunocompromised Hosts
por: Conlon, Christopher
Publicado: (2000)

The Importance of Serum Procalcitonin in Diagnosis and Treatment of Serious Bacterial Infections and Sepsis
por: Mehanic, Snjezana, et al.
Publicado: (2013)

Procalcitonin, a marker of bacterial infection
por: Gendrel, D., et al.
Publicado: (1997)

1334. Performance of C-Reactive Protein and Procalcitonin in Immunocompromised Children with SIRS
por: Posch, Leila C, et al.
Publicado: (2019)

Procalcitonin: A Reliable Marker for the Diagnosis of Neonatal Sepsis
por: Adib, Minoo, et al.
Publicado: (2012)

Serum procalcitonin as a diagnostic marker of neonatal sepsis
por: Park, In Ho, et al.
Publicado: (2014)

Procalcitonin as prognostic marker in severe sepsis of abdominal origin
por: Gonzalez-Lisorge, A, et al.
Publicado: (2015)

Procalcitonin as an adjunctive biomarker in sepsis
por: Sinha, Mahua, et al.
Publicado: (2011)

Procalcitonin in autoimmune disease with sepsis
por: Leonhardt, U, et al.
Publicado: (2001)

Significance of serum procalcitonin in sepsis
por: Sudhir, Uchil, et al.
Publicado: (2011)

Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary Tuberculosis
por: Lomtadze, Nino, et al.
Publicado: (2013)

Procalcitonin Is a Marker of Gram-Negative Bacteremia in Patients With Sepsis
por: Guo, Shun Yuan, et al.
Publicado: (2015)

Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy
por: Vijayan, Ashitha L., et al.
Publicado: (2017)

Procalcitonin-guided antibiotics in severe sepsis
por: Simon, Peter, et al.
Publicado: (2008)

Procalcitonin – Assisted Antibiotic Strategy in Sepsis
por: Trásy, Domonkos, et al.
Publicado: (2017)

Efficacy of measuring procalcitonin levels in determination of prognosis and early diagnosis of bacterial resistance in sepsis
por: Dolatabadi, Ali Arhami, et al.
Publicado: (2015)

Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study
por: Schuetz, Philipp, et al.
Publicado: (2017)

Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin
por: López Sastre, José B, et al.
Publicado: (2006)

Procalcitonin as a prognostic marker for sepsis: a prospective observational study
por: Jain, Saransh, et al.
Publicado: (2014)

Procalcitonin as a marker of sepsis and outcome in patients with neurotrauma: an observation study
por: Deng, Shuixiang, et al.
Publicado: (2013)

Procalcitonin kinetics as a prognostic marker in severe sepsis/septic shock
por: Poddar, Banani, et al.
Publicado: (2015)

Population Size Estimation of Men Who Have Sex with Men in Tbilisi, Georgia; Multiple Methods and Triangulation of Findings
por: Sulaberidze, Lela, et al.
Publicado: (2016)

What procalcitonin brings to management of sepsis in the ICU
por: Wolff, Michel, et al.
Publicado: (2010)

Evaluation of procalcitonin in patients with sepsis in Albanian adults
por: Puca, E, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o145urkltsg8gto1gct9feigi3